ARCHIVE

• Takeda, Pharmacia to Launch Smoking Cessation Aid Nicorette in September
  August 20, 2001

• Tiracoxib Designated as Orphan for Familial Adenomatous Polyposis
  August 20, 2001

• Asahi Kasei Licenses Out Fasudil to Schering AG
  August 20, 2001

• Genomic Drug Discovery, Tailor-Made Medicine to Receive Top Priority in FY2002 Budgeting
  August 20, 2001

• Takeda, Bayer to Discuss with Korosho on Cerivastatin
  August 20, 2001

• Generics of 20 Drugs to Be Tested: 14th Quality Reevaluation
  August 20, 2001

• Daiichi to Clear Goals for 1st Half of FY2001: President Morita
  August 20, 2001

• 29 Mono-drugs, 1 Combination Designated: 15th Quality Reevaluation
  August 20, 2001

• Nippon Chemiphar to Shift from Restructuring to Business Expansion: President Yamaguchi
  August 6, 2001

• Mechanisms for Cancer Onset, Metastasis Expected to Be Clarified in 2014: Monkasho Survey
  August 6, 2001

• Wishing to Launch Drugs in Japan within 6 Months of the 1st Launch Overseas: Dr Kato of AstraZeneca
  August 6, 2001

• GSK, Shionogi to Establish Overseas Joint Venture
  August 6, 2001

• REGULATORY NEW IN BRIEF
  August 6, 2001

• Taiho Aims at Becoming World Leader in Oncology: Mid-term Plan
  August 6, 2001

• Blood Glucose Control Improved by Ultra-fast Acting Insulin: Lilly Symposium
  August 6, 2001

• Nippon Kayaku to Place Top Priority on R&D
  August 6, 2001

• Large Studies Required to Verify Inhibition of Cardiovascular Events: Sankyo Seminar
  August 6, 2001

• Morishita Jintan to Expand Seamless Microcapsule Business
  August 6, 2001

• Saitama Medical School to Establish Genomic Medicine Research Center
  August 6, 2001

• Pfizer to Increase Number of MRs to 2,300 in 2005: Survey
  August 6, 2001

ページ

• « 先頭
• ‹ Prev
• …
• 737
• 738
• 739
• 740
• 741
• 742
• 743
• 744
• 745
• …
• Next ›
• 最終 »